Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer von Wang, Jingyuan, Xiu, Joanne, Battaglin, Francesca, Arai, Hiroyuki, Soni, Shivani, Zhang, Wu, Goldberg, Richard M., Philip, Philip A., Seeber, Andreas, Hwang, Jimmy J., Shields, Anthony F., Marshall, John L., Astaturov, Igor, Liu, Tianshu, Lockhart, A. Craig, Korn, W. Michael, Shen, Lin, Lenz, Heinz-Josef

Volltext

Abstract A018: Patient-derived xenograft (PDX) models of NSCLC reflect clinical drug responses and predict effective treatments for patients von Ciznadija, Daniel, Astaturov, Igor, Cheng, Haiying, Peled, Nir, Jaskowiak, Jennifer, Davies, Angela, Sidransky, David

Volltext

First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer von Winer, Arthur, Denlinger, Crystal S., Vijayvergia, Namrata, Cohen, Steven J., Astaturov, Igor, Dotan, Efrat, Gallant, Jean-Nicolas, Wang, Edward W., Kunkel, Miriam, Lim, Bora, Harvey, Harold A., Sivik, Jeffrey, Korzekwa, Kenneth, Ruth, Karen, White, Kevin, Cooper, Harry S., Ross, Eric A., Zhou, Lanlan, El-Deiry, Wafik S.

Volltext